EBIOMEDICINE 润色咨询

EBioMedicine

出版年份：2014 年文章数：2279 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2016-03-14 刘洋1981

    你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。fulin2222 2016-03-14 发表::
    我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右

    fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2019-05-11 haiyang0518

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2024-04-09 ms6000001986535996 来自上海

    审稿速度:2.0
    经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2024-03-29 ms3000000561056569 来自辽宁省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：经过了圣诞节，实际上可能只用了三周返回稿件

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2023-12-11 ms1000000959787142 来自天津

    各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2022-10-20 y-y-y

    审稿速度:2.0
    偏重的研究方向：转化医学;临床转化
    经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2024-01-17 ms2000000395345853 来自四川省

    偏重的研究方向：转化医学
    经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2023-08-25 dujiang 来自河南省

    偏重的研究方向：转化医学
    经验分享：三天拒稿

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2023-11-07 ms4000002052355520 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：微生态
    经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去.

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=520174, encodeId=93705201e435, content=你看上面文章觉得几分的水平，我觉得目前至少完爆SR，你的文章水平你觉得是多少分？这个刊物要求并不低，柳叶刀子刊最差的也是9分，这个新刊今年不会低于5，而且有超过NC的潜力。我们投四大刊悲剧了，都推荐投各自子刊，综合考虑选择了这个，我们文章水平实话说，确实十分以上。<span class="quote">fulin2222 2016-03-14 发表::<br>我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右</span>, beContent=fulin2222 2016-03-14 发表:: 我刚投了一篇，也挺关心的，据有人推测今年好像只有2分左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Mar 14 08:03:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0<br>经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0<br>偏重的研究方向：转化医学;临床转化<br>经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学<br>经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学<br>经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生态<br>经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰)]
    2023-07-12 guolihuihelan_91618321 来自荷兰

    审稿速度:12.0 | 投稿命中率:5.0
    经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分